SEPN - Septerna, Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
EPS Est: $-0.23
|
Rev Est: $17.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.75
DETAILS
HIGH:
$38.00
LOW:
$28.00
MEDIAN:
$34.50
CONSENSUS:
$33.75
UPSIDE:
9.36%
Market Cap:
1.38B
Volume:
334,829
Avg Volume:
300,420
52 Week Range:
4.66-31.37
Sector:
Healthcare
Industry:
Biotechnology
Beta:
3.85
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
75
IPO Date:
2024-10-25
EPS (TTM):
-7.26
P/E Ratio:
-3.15
Revenue (TTM):
1.07M
Total Assets:
456.55M
Total Debt:
25.48M
Cash & Equiv:
238.20M
Rev Growth (5Y):
611.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-18.2%
Debt/Equity:
0.06
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.09 | $0.19 | -147.4% | $21.5M | $17.3M | +24.5% |
| 2025-08-11 | $-0.56 | $-0.05 | -1020.0% | $119000 | $5.0M | -97.6% |
| 2025-05-15 | $-0.49 | $-0.38 | -28.9% | $219000 | $30.0M | -99.3% |
| 2025-03-27 | $-0.64 | $-0.69 | +7.2% | $212000 | — | — |
| 2024-11-21 | $-8.40 | $-0.83 | -912.0% | $176000 | — | — |
| 2023-12-31 | $2.05 | — | — | $118000 | — | — |
| 2023-09-30 | $-0.56 | — | — | $33000 | — | — |
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.07M | 151,000 | 0 |
| Net Income | (71.80M) | 4.18M | (27.68M) |
| EPS | -7.26 | 0.03 | -1.42 |
| Total Assets | 456.55M | 130.87M | 36.12M |
| Total Debt | 25.48M | 12.57M | 710,000 |
| Cash & Equivalents | 238.20M | 88.48M | 30.61M |
| Operating Cash Flow | (67.47M) | (38.72M) | (23.30M) |
| Free Cash Flow | (69.57M) | (41.60M) | (24.59M) |
| FCF per Share | -7.03 | -2.13 | -1.26 |
| Book Value | 420.05M | (38.37M) | (44.20M) |
| Cash & ST Investments | 350.92M | 88.48M | 30.61M |
| ROC Equity | -0.17 | N/A | N/A |